Home » Topics » Regulatory » Patents

Patents
RSS

Cervello Therapeutics describes new Rho-associated protein kinase inhibitors

Sep. 9, 2020

New thyroid hormone receptor alpha/beta agonists discovered at Nanjing Ruijie Pharma

Sep. 9, 2020

Sichuan Kelun-Biotech Biopharmaceutical patents NLRP3 agonists

Sep. 9, 2020

Asceneuron discovers N-acetyl-beta-D-glucosaminidase inhibitors

Sep. 9, 2020

Janssen describes new anti-hepatitis B virus compounds

Sep. 9, 2020

Enterin identifies new PTP-1B inhibitors

Sep. 8, 2020

New PCSK9 inhibitors presented by the Wisconsin Alumni Research Foundation

Sep. 8, 2020

Shenzhen Targetrx Biotechnology discovers RET inhibitors

Sep. 8, 2020

Adlai Nortye describes new PD-1/PD-L1 interaction inhibitors

Sep. 8, 2020

New Nav1.8 channel blockers patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Sep. 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...